Horizon Pharma Plc (HZNP)

20.95
NASDAQ : Health Technology
Prev Close 20.95
Day Low/High 0.00 / 0.00
52 Wk Low/High 11.17 / 21.25
Avg Volume 1.69M
Exchange NASDAQ
Shares Outstanding 166.63M
Market Cap 3.49B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Sell Alert: These 5 Stocks Look Toxic Right Now

Sell Alert: These 5 Stocks Look Toxic Right Now

It's time to unload these toxic stocks from your portfolio.

A Move Lower Is on the Horizon (Pharma)

Don't be surprised if HZNP trends lower to next chart support around $10.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ASM, BAC, BERY, CNP, DF, HAIN, HPT, IBTX, LVNTA, LVNTB, PNK, TSEM Downgrades: GSVC, HZNP, NC, PRA Initiations: SMMT Read on to get TheStreet Quant Ratings' detailed report:

Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Teva Reports Better-Than-Expected Q1 As Revenue from Branded Biz Beats Estimates

Teva Reports Better-Than-Expected Q1 As Revenue from Branded Biz Beats Estimates

Teva Pharmaceutical Industries reported adjusted earnings of $1.20 a share for Q1, topping analysts expectation of $1.17.

Horizon Pharma Needs a Health Check

HZNP could work lower to $10 in the weeks and months ahead.

Depomed Jumps After Mizuho Says Buy Amid Rising Takeover Chances

Depomed Jumps After Mizuho Says Buy Amid Rising Takeover Chances

Shares of Depomed are on the rise after research firm Mizuho upgraded shares to Buy on its view of an increased takeout probability following Starboard Value's CEO Jeffrey Smith's comments...

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Cramer says he's looking forward to another week of earnings to see which bull markets are alive and well.

AAPL, AMZN, SQ: Jim Cramer's Views

AAPL, AMZN, SQ: Jim Cramer's Views

Jim Cramer shares his views on how collateral damage is harming stocks and discusses what the jobs report means. Apple, Amazon and Square are among the stocks discussed here.

Cramer: Collateral Damage Is Giving These Stocks a Bad Name

But for the brave, they could offer a solid bottom-fishing opportunity.

Horizon Pharma (HZNP) Falling In After-Hours Activity

Horizon Pharma (HZNP) Falling In After-Hours Activity

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a post-market laggard candidate

Jeffrey Smith Says It's Time to Buy Depomed and WestRock: Sohn 2016

Jeffrey Smith Says It's Time to Buy Depomed and WestRock: Sohn 2016

Activist Jeffrey Smith took the Sohn stage Wednesday highlighting stocks Starboard finds undervalued.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Horizon Pharma Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 9, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Horizon Pharma Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 9, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Horizon Pharma plc ("Horizon" or the "Company") (Nasdaq:HZNP)...

HZNP INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Horizon Pharma PLC

HZNP INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Horizon Pharma PLC

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased...

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Horizon Pharma plc (NASDAQ:HZNP) securities...

Today's Dead Cat Bounce Stock Is Horizon Pharma (HZNP)

Today's Dead Cat Bounce Stock Is Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Here's Why Horizon Pharma (HZNP) Stock Is Tanking Today

Here's Why Horizon Pharma (HZNP) Stock Is Tanking Today

Horizon Pharma (HZNP) stock is plunging in afternoon trading Tuesday after the company issued weaker-than-expected first quarter 2016 guidance.

Heavy Trading On Horizon Pharma (HZNP) Before Market Open

Heavy Trading On Horizon Pharma (HZNP) Before Market Open

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a pre-market mover with heavy volume candidate

'Mad Money' Lightning Round: UnitedHealth May Be the Dow's Best Stock

'Mad Money' Lightning Round: UnitedHealth May Be the Dow's Best Stock

Cramer says buy Mattel under $30 but avoid Acorda Therapeutics.

Jim Cramer's 'Mad Money' Recap: These Stocks Are New-High Winners

Jim Cramer's 'Mad Money' Recap: These Stocks Are New-High Winners

Cramer says the market's diverse leadership is a very bullish sign.

HORIZON PHARMA Plc SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

HORIZON PHARMA Plc SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Horizon Pharma plc (NASDAQ: HZNP) securities...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Horizon Pharma Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 9, 2016 - HZNP

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Horizon Pharma Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 9, 2016 - HZNP

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Horizon Pharma plc ("Horizon" or the "Company") (Nasdaq:HZNP)...

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Horizon Pharma Plc Investors And Encourages Investors To Contact The Firm

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Horizon Pharma Plc Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Horizon Pharma plc ("Horizon Pharma" or the "Company") (NYSE: HZNP) securities between...

HZNP INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Horizon Pharma PLC

HZNP INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Horizon Pharma PLC

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of investors who purchased or otherwise acquired the securities of Horizon Pharma PLC ("Horizon"...

INVESTOR ALERT: The Law Offices Of Vincent Wong Remind Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Remind Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District District of New York on behalf of investors who purchased Horizon Pharma plc (NASDAQ: HZNP)...

STOCK ALERT: Rosen Law Firm Reminds Horizon Pharma Plc Investors Of Important Deadline In Class Action - HZNP

STOCK ALERT: Rosen Law Firm Reminds Horizon Pharma Plc Investors Of Important Deadline In Class Action - HZNP

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Horizon Pharma plc securities (NASDAQ:HZNP) from March 13, 2014 through February 26, 2016, all dates inclusive (the "Class Period") of the important...

Horizon Pharma (HZNP) Is Today's Strong On High Volume Stock

Horizon Pharma (HZNP) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

TheStreet Quant Rating: D (Sell)